MMM 3M COMPANY

Revolutionary Skin Protectant Finally Gives Nurses the Power to Stop, Reverse and Prevent Incontinence Associated Dermatitis

As our aging population grows, nurses are continuing to see more instances of tough-to-manage skin breakdown due to incontinence. Skin damage associated with urine and/or fecal exposure, otherwise known as incontinence associated dermatitis (IAD), is a resource-intensive condition that can be very painful for patients. To help combat this debilitating problem, 3M introduces its revolutionary 3M™ Cavilon™ Advanced Skin Protectant, a high endurance skin protectant designed to stop, reverse and prevent the damaging effects of moderate to severe IAD. The new skin protectant provides clinicians with an easier, more effective way to manage patients with IAD to help improve their quality of life and overall patient experience.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170201006018/en/

3M Cavilon Advanced Skin Protectant (Photo: 3M)

3M Cavilon Advanced Skin Protectant (Photo: 3M)

“Moisture barriers used today to prevent and manage IAD are outdated and have significant limitations that impact their clinical effectiveness. The introduction of 3M Cavilon Advanced Skin Protectant, a game-changing barrier technology, represents an exciting leap forward for patients suffering with IAD,” said Todd Fruchterman, MD, PhD, Vice President and General Manager for the 3M Critical & Chronic Care Solutions Division. “Cavilon Advanced Skin Protectant delivers compelling clinical and infection control benefits, while offering greater comfort and protection to patients, and giving institutions and nurses a more economical way to deliver effective and compassionate care.”

Cavilon Advanced Skin Protectant has several benefits that will help reshape the standard of care for patients with IAD and other types of severe skin damage. These include:

Durable barrier provides comfort and protection in the toughest environments

Cavilon Advanced Skin Protectant is effective for those at risk of developing IAD and in conditions where skin is frequently or continuously exposed to moisture and caustic irritants such as diarrhea, digestive fluids, wound drainage and urine. It creates an effective, long-lasting barrier on both intact and wet, weeping skin. The high endurance skin protectant is breathable and comfortable through application, wear and cleansing processes. Cavilon Advanced Skin Protectant also helps reduce the risks that contribute to pressure ulcers/injuries.

Fewer reapplications and no need for removal means less potential disruption to skin

Removal and reapplication of traditional pastes and ointments to manage IAD can be painful for patients and time-consuming for nursing staff. Cavilon Advanced Skin Protectant provides an effective barrier for up to seven days and wears away naturally. This unique barrier not only saves staff time, but also helps create a healing environment for damaged skin.

Easy application and monitoring frees up nursing staff to provide quality patient care

The easy-to-use, single-use applicator makes application faster and easier for nurses. It allows for easy cleansing between applications, where nurses can simply remove stool or other soil without disturbing the film or skin. The transparent barrier also provides easy visualization of the underlying skin, making it easier for nurses to monitor the condition. The single-use applicator also helps avoid potential contamination associated with multi-use tubes, thus providing benefits for infection control.

Remarkable science applied to revolutionizing IAD care

The Cavilon brand has long been synonymous with utilizing novel polymer chemistry to develop solutions for skin protection and to aid in maintaining skin integrity. Cavilon Advanced Skin Protectant continues with that tradition and features unique chemistry that achieves elasticity of the polymer system, assuring great barrier integrity and durability. 3M’s polymer-cyanoacrylate system enables the barrier to flex and stretch with the skin and aid in creating a healing environment for even the most damaged skin. The liquid is non-stinging and the protective film coating reduces pain and suffering associated with IAD.

“IAD is such a challenging condition for clinicians to manage due to the frequency of incontinence episodes and the caustic irritants that damage the skin,” shared Bob Asmus, lead scientist for Cavilon Advanced Skin Protectant. “We saw the need for a barrier which could adhere to moist, weepy skin and provide protection from severe incontinence while providing a protective environment for the skin to heal and reducing pain and discomfort to the patient.”

3M has a long history of applying science to develop innovative skin and wound care products that protect and maintain skin integrity. Cavilon Advanced Skin Protectant is a true breakthrough that complements 3M’s comprehensive skin care solution portfolio well. For more information on IAD prevention and 3M’s skin integrity solutions, please visit 3M.com/EndIAD.

About 3M

At 3M, we apply science in collaborative ways to improve lives daily. With $30 billion in sales, our 90,000 employees connect with customers all around the world. Learn more about 3M’s creative solutions to the world’s problems at www.3M.com or on Twitter @3M or @3MNewsroom.

EN
01/02/2017

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on 3M COMPANY

3M Company - September 2025 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

3M Co: 1 director

A director at 3M Co sold 3,477 shares at 150.630USD and the significance rating of the trade was 74/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing C...

Moody's Ratings announces completion of a periodic review of ratings o...

Moody's Ratings (Moody's) has completed a periodic review of the ratings of 3M Company and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 16 May 2025 in which we reassessed the appropriateness of the ratings in the context of the rele...

Moody's Ratings assigns A3 rating to 3M Company's new unsecured notes

Moody's Ratings (Moody's) assigned an A3 rating to the new senior unsecured notes (Notes) that 3M Company (3M) announced earlier today. We expect the company will use the net proceeds for general corporate purposes, including the repayment, redemption or refinancing of a portion of its outstanding 2...

3M Company - September 2024 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch